A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 4, 2011, Pages 181-188

  Namwanje, Harriet ^a   Kabatereine, Narcis ^a   Olsen, Annette ^b  

^a MINISTRY OF HEALTH   (Uganda)

^b DANISH BILHARZIASIS LABORATORY   (Denmark)

Author keywords

Combination drug therapy; Drug safety; Lymphatic filariasis; Schistosomiasis; Soil transmitted helminthiasis; Uganda

Indexed keywords

ALBENDAZOLE; IVERMECTIN; PRAZIQUANTEL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIZZINESS; DRUG SAFETY; DYSPNEA; HEADACHE; HELMINTHIASIS; HUMAN; LIVER FUNCTION TEST; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMIASIS; SINGLE BLIND PROCEDURE; TROPICAL DISEASE; UGANDA; VOMITING; WEAKNESS;

ADOLESCENT; ALBENDAZOLE; ANIMALS; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; FEMALE; HELMINTHIASIS; HUMANS; IVERMECTIN; MALE; PRAZIQUANTEL; SCHISTOSOMIASIS; SENTINEL SURVEILLANCE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; UGANDA;

SCHISTOSOMA MANSONI;

EID: 79952898087     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.11.012     Document Type: Article

References (29)

1. Michael E., Bundy D.A.P., Grenfell B.T. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996, 112:409-428.
2. Ottesen E.A., Duke B.O.L., Karam M., Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
3. WHO Preventive chemotherapy in human helminthiasis. Guidelines for professionals and programme managers 2006, World Health Organization, Geneva.
4. Onapa A.W., Simonsen P.E., Baehr I., Pedersen E.M. Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Ann Trop Med Parasitol 2005, 99:141-153.
5. Horton J., Witt C., Ottesen E.A., Lazdins J.K., Addiss D.G., Awadzi K., et al. An analysis of the safety of single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000, 121(Suppl):S147-S160.
6. WHO. The prevalence of anemia in women: a tabulation of available information. 2nd ed. Maternal Health and Safe Motherhood Programme. Geneva: World Health Organization; 1992. WHO/MCH/MSM/92.2.
7. Stephenson L.S., Latham M.C., Kurz K.M., Kinoti S.N., Brigham H. Treatment with a single dose of albendazole improves growth of Kenyan schoolchildren with hookworm, Trichuris trichiura and Ascaris lumbricoides infections. Am J Trop Med Hyg 1989, 41:78-87.
8. WHO WHO model prescribing information: drugs used in parasitic diseases 1995, World Health Organization, Geneva.
9. WHO A safer future: global public health security in the 21st century 2007, World Health Organization, Geneva.
10. Olds G.R., King C., Hewlett J., Olveda R., Wu G., Ouma J., et al. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J Infect Dis 1999, 179:996-1003.
11. Kolaczinski J.H., Kabatereine N.B., Onapa A.W., Ndyomugyenyi R., Kakembo A.S., Brooker S. Neglected tropical diseases in Uganda: the prospect and challenge of integrated control. Trends Parasitol 2007, 23:485-493.
12. Na-Bangchang K., Kietinun S., Pawa K.K., Hanpitakpong W., Na-Bangchang C., Lazdins J. Assessment of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Trans R Soc Trop Med Hyg 2006, 100:335-345.
13. Mohammed K.A., Haji H.J., Gabrielli A.F., Mubila L., Biswas G., Chitsulo L., et al. Triple co-administration of ivermectin, albendazole and praziquantel in Zanzibar: a safety study. PLoS Negl Trop Dis 2008, 2:e171.
14. Eigege A., Pede E., Miri E., Umaru J., Ogbu Pearce P., Jinadu M.Y., et al. Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria. Ann Trop Med Parasitol 2008, 102:177-179.
15. Kabatereine NB. Schistosoma mansoni in a fishing community on the shores of Lake Albert at Butiaba, Uganda. Epidemiology, morbidity, re-infection and impact of treatment with praziquantel [PhD thesis]. Copenhagen: Faculty of Science, University of Copenhagen; 2000.
16. Uganda Bureau of Statistics Population and social statistics 2002, Uganda Bureau of Statistics, Uganda.
17. WHO. Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. Geneva: World Health Organization; 1995. Technical Report Series No. 850, Annex 3.
18. Jamshaid I., Ali S. Determination of the prevalence of lymphatic filariasis among migrant workers in Kuwait by detecting circulating filarial antigen. J Med Microbiol 2006, 55:401-405.
19. Bruschi F., Castagna B. The serodiagnosis of parasitic infections. Parasitology 2004, 46:141-144.
20. Dati F., Schumann G., Thomas L., Aguzzi F., Baudner S., Bienvenu J., et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996, 34:517-520.
21. Babu B.V., Rath K.A.S., Kerketta B.K., Swain M.S., Kar S.K. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. Trans R Soc Trop Med Hyg 2004, 100:464-469.
22. Babu B.V., Satyanarayana K. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India. Trop Doct 2003, 33:79-82.
23. McLaughlin S.I., Radday J., Michel M.C., Addiss D.G., Beach M.J., Lammie P.J., et al. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. Am J Trop Med Hyg 2003, 68:568-573.
24. Ramaiah K.D., Das P.K., Appavoo N.C., Ramu K., Augustin D.J., Kumar K.N., et al. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health 2000, 12:842-847.
25. Dreyer G., Pires M.L., de Andrade L.D., Lopes E., Medeiros Z., Tenorio J., et al. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 1994, 88:232-236.
26. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 2003, 81:343-352.
27. Beach M.J., Streit T.G., Prospere R.A., Roberts J.M., Lammie J.P. Assessment of combined ivermectin and albendazole for the treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian school children. Am J Trop Med Hyg 1999, 60:479-486.
28. Davis A. Antischistosomal drugs and clinical practice. Human schistosomiasis 1993, 367-404. CAB International, Wallingford. P. Jordan, G. Webbe, R.F. Sturrock (Eds.).
29. Kabatereine N.B., Kemijumbi J., Ouma J.H., Sturrock R.F., Butterworth A.E., Madsen H., et al. Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg 2003, 97:599.